Jundishapur Journal of Microbiology

Published by: Kowsar

Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran

Mohammad Yousef Alikhani 1 , Zahra Karimi Tabar 1 , Fatemeh Mihani 1 , Enayat Kalantar 2 , Pegman Karami 1 , Mahnaz Sadeghi 3 , Shiva Ahdi Khosroshahi 4 and Safar Farajnia 5 , *
Authors Information
1 Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Alborz, IR Iran
3 Tuberculosis and Lung Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: January 01, 2014, 7 (1); e8888
  • Published Online: January 1, 2014
  • Article Type: Research Article
  • Received: November 15, 2012
  • Revised: January 23, 2013
  • Accepted: March 14, 2013
  • DOI: 10.5812/jjm.8888

To Cite: Alikhani M Y, Karimi Tabar Z, Mihani F, Kalantar E, Karami P, et al. Antimicrobial Resistance Patterns and Prevalence of blaPER-1 and blaVEB-1 Genes Among ESBL-producing Pseudomonas aeruginosa Isolates in West of Iran, Jundishapur J Microbiol. 2014 ; 7(1):e8888. doi: 10.5812/jjm.8888.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy. J Clin Microbiol. 2004; 42(6): 2523-9[DOI][PubMed]
  • 2. Isturiz RE, Carbon C. Antibiotic use in developing countries. Infect Control Hosp Epidemiol. 2000; 21(6): 394-7[DOI][PubMed]
  • 3. Livermore DM, Brown DF. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother. 2001; 48 Suppl 1: 59-64[PubMed]
  • 4. Ben-Mahrez Kamel, Rejiba Samia, Belhadj Cherifa, Belhadj Omrane. β-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa. Res Microbiol. 1999; 150(6): 403-406[DOI]
  • 5. Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother. 2005; 56(1): 122-7[DOI][PubMed]
  • 6. Poirel L, Lebessi E, Castro M, Fevre C, Foustoukou M, Nordmann P. Nosocomial outbreak of extended-spectrum beta-lactamase SHV-5-producing isolates of Pseudomonas aeruginosa in Athens, Greece. Antimicrob Agents Chemother. 2004; 48(6): 2277-9[DOI][PubMed]
  • 7. Weldhagen GF. Rapid detection and sequence-specific differentiation of extended-spectrum beta-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay. Antimicrob Agents Chemother. 2004; 48(10): 4059-62[DOI][PubMed]
  • 8. Essack SY. Laboratory detection of extended-spectrum β-lactamases (ESBLs)—The need for a reliable, reproducible method. Diag Microbiol Infect Dis. 2000; 37(4): 293-295[DOI]
  • 9. Jacoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 1996; 34(4): 908-11[PubMed]
  • 10. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003; 41(8): 3542-7[PubMed]
  • 11. Wolska MK, Bukowski K, Jakubczak A. [Occurrence of beta-lactamase type ESBL and IBL in Pseudomonas aeruginosa rods]. Med Dosw Mikrobiol. 2001; 53(1): 45-51[PubMed]
  • 12. Aubert D, Poirel L, Chevalier J, Leotard S, Pages JM, Nordmann P. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2001; 45(6): 1615-20[DOI][PubMed]
  • 13. Endimiani A, Luzzaro F, Pini B, Amicosante G, Rossolini GM, Toniolo AQ. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase. BMC Infect Dis. 2006; 6: 52[DOI][PubMed]
  • 14. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 15. Wayne PA. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement NCCLS document M100-S9. National Committee for Clinical Laboratory Standards. 2008;
  • 16. Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, et al. Detection of metallo-beta-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis. 2010; 68(3): 322-5[DOI][PubMed]
  • 17. Sohrabi N, Farajnia S, Akhi MT, Nahaei MR, Naghili B, Peymani A, et al. Prevalence of OXA-type beta-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 2012; 18(4): 385-9[DOI][PubMed]
  • 18. Todar Kenneth. Todar's online textbook of bacteriology. 2006;
  • 19. Hauser AR, Sriram P. Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad Med. 2005; 117(1): 41-8[PubMed]
  • 20. Chayakulkeeree M, Junsriwong P, Keerasuntonpong A, Tribuddharat C, Thamlikitkul V. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003. Southeast Asian J Trop Med Public Health. 2005; 36(6): 1503-9[PubMed]
  • 21. Kaushik Robin, Kumar Sandeep, Sharma Rajeev, Lal Pawanindra. Bacteriology of burn wounds — the first three years in a new burn unit at the Medical College Chandigarh. Burns. 2001; 27(6): 595-597[DOI]
  • 22. Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2010; 36(1): 70-4[DOI][PubMed]
  • 23. Nikbin VS, Abdi-Ali A, Feizabadi MM, Gharavi S. Pulsed field gel electrophoresis & plasmid profile of Pseudomonas aeruginosa at two hospitals in Tehran, Iran. Indian J Med Res. 2007; 126(2): 146-51[PubMed]
  • 24. Ozumba UC, Jiburum BC. Bacteriology of burn wounds in Enugu, Nigeria. Burns. 2000; 26(2): 178-180[DOI]
  • 25. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother. 2006; 57(5): 975-8[DOI][PubMed]
  • 26. Chanawong A, M'Zali FH, Heritage J, Lulitanond A, Hawkey PM. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum beta-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J Antimicrob Chemother. 2001; 48(6): 839-52[PubMed]
  • 27. Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009; 15(1): 37-9[DOI][PubMed]
  • 28. Tsakris A, Vatopoulos AC, Tzouvelekis LS, Legakis NJ. Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa. Eur J Epidemiol. 1992; 8(6): 865-70[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments